{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_15120", "batch_size": 260, "batch_pos": 165, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "The verbs 'said', 'begin', and 'expected' are neutral.", "method": "llm_batch", "batch_id": "batch_2_17528", "batch_size": 260, "batch_pos": 163, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "The segment discusses future testing and expected results, not the virus's realised impact.", "method": "llm_batch", "batch_id": "batch_3_14580", "batch_size": 260, "batch_pos": 143, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_7416", "batch_size": 260, "batch_pos": 142, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "The segment reports testing timeline but lacks an explicit calming cue.", "method": "llm_batch", "batch_id": "batch_5_6596", "batch_size": 260, "batch_pos": 141, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "The segment does not contain a minimiser used in conjunction with a scale contrast.", "method": "llm_batch", "batch_id": "batch_6_17096", "batch_size": 260, "batch_pos": 136, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation cue.", "method": "llm_batch", "batch_id": "batch_7_14640", "batch_size": 260, "batch_pos": 132, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 8, "answer": "yes", "rationale": "States a future plan/timeline ('late-stage testing would begin in 2025'), relating to future vaccine development, a capability.", "method": "llm_batch", "batch_id": "batch_8_14580", "batch_size": 260, "batch_pos": 116, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
